John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$172M |
| 2 |
Johnson & Johnson
JNJ
|
+$161M |
| 3 |
American Express
AXP
|
+$161M |
| 4 |
Apple
AAPL
|
+$156M |
| 5 |
Emerson Electric
EMR
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$172M |
| 2 |
AGN
Allergan Inc
AGN
|
+$139M |
| 3 |
Wynn Resorts
WYNN
|
+$111M |
| 4 |
AbbVie
ABBV
|
+$94.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$94.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.92% |
| 2 | Technology | 11.5% |
| 3 | Industrials | 10.9% |
| 4 | Healthcare | 10.87% |
| 5 | Consumer Staples | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Amphenol
APH
$192B
| $1.98M | 0.01% |
+134,076
| New | +$1.88M |
|
1177
Rambus
RMBS
$9.44B
| $1.98M | 0.01% |
157,027
+15,801
| +11% | +$186K |
|
|
PERY
1178
DELISTED
Perry Ellis International Inc
PERY
| $1.97M | 0.01% |
85,223
-10,377
| -11% | -$248K |
|
1179
Stantec
STN
$8.34B
| $1.97M | 0.01% |
82,399
-144,702
| -64% | -$3.67M |
|
1180
CALL
American International
AIG
$40.5B
| $1.97M | 0.01% |
+36,000
| New | +$1.93M |
|
|
EGRX
1181
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.97M | 0.01% |
+47,005
| New | +$1.33M |
|
|
SCLN
1182
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $1.97M | 0.01% |
222,265
+32,149
| +17% | +$256K |
|
1183
Forward Air
FWRD
$594M
| $1.96M | 0.01% |
+36,079
| New | +$1.84M |
|
1184
Costamare
CMRE
$1.88B
| $1.95M | 0.01% |
110,448
-27,846
| -20% | -$504K |
|
1185
PUT
Archer Daniels Midland
ADM
$37.7B
| $1.94M | 0.01% |
+41,000
| New | +$1.95M |
|
1186
PUT
Fluor
FLR
$6.86B
| $1.94M | 0.01% |
+34,000
| New | +$1.93M |
|
|
RUTH
1187
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $1.94M | 0.01% |
+122,367
| New | +$1.85M |
|
1188
Hanmi Financial
HAFC
$926M
| $1.94M | 0.01% |
91,828
+31,589
| +52% | +$649K |
|
1189
Outfront Media
OUT
$5.36B
| $1.94M | 0.01% |
65,861
-169,431
| -72% | -$4.82M |
|
|
VR
1190
DELISTED
Validus Hold Ltd
VR
| $1.94M | 0.01% |
46,072
-135,670
| -75% | -$5.59M |
|
|
MPT
1191
Medical Properties Trust
MPT
$2.46B
| $1.94M | 0.01% |
131,579
+17,533
| +15% | +$260K |
|
1192
Vishay Precision Group
VPG
$881M
| $1.94M | 0.01% |
121,546
+92,957
| +325% | +$1.49M |
|
1193
Watts Water Technologies
WTS
$12.4B
| $1.94M | 0.01% |
+35,180
| New | +$2.01M |
|
|
BFX
1194
DELISTED
BowFlex Inc.
BFX
| $1.94M | 0.01% |
126,801
+98,981
| +356% | +$1.5M |
|
1195
PUT
Bank of America
BAC
$436B
| $1.93M | 0.01% |
+125,600
| New | +$2.02M |
|
1196
TriplePoint Venture Growth BDC
TPVG
$217M
| $1.93M | 0.01% |
136,975
+103,770
| +313% | +$1.51M |
|
|
STBZ
1197
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
| $1.93M | 0.01% |
92,005
-13,488
| -13% | -$267K |
|
1198
Greenlight Captial
GLRE
$507M
| $1.93M | 0.01% |
60,662
+34,690
| +134% | +$1.11M |
|
|
LM
1199
DELISTED
Legg Mason, Inc.
LM
| $1.92M | 0.01% |
+34,862
| New | +$1.96M |
|
|
AVX
1200
DELISTED
AVX Corporation
AVX
| $1.92M | 0.01% |
134,830
+102,569
| +318% | +$1.41M |
|
Similar funds
John Overdeck's Q1 2015 Portfolio in Review
As of Q1 2015, John Overdeck held 3,174 positions worth $21.5B, up 19% from $18.1B the previous quarter. Its ten largest holdings account for 7.3% of the portfolio.
John Overdeck deployed $3.03B of net new capital in Q1 2015, opening 981 new positions and adding to 805 existing holdings. Its largest new stake was Intel: 5,084,443 shares worth $159M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 10% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was AbbVie, an estimated $94.4M trimmed.
- John Overdeck's largest Q1 2015 buy was Intel: 5,084,443 shares worth $159M.
- John Overdeck added most to Johnson & Johnson in Q1 2015, an estimated $161M increase.
- John Overdeck's biggest Q1 2015 reduction was AbbVie, cutting an estimated $94.4M.
- John Overdeck fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $172M.
- John Overdeck's ten largest holdings make up 7.3% of its $21.5B portfolio in Q1 2015.
- John Overdeck opened 981 new positions and closed 576 in Q1 2015.
- John Overdeck's portfolio value rose 19% quarter-over-quarter to $21.5B.
Based on Two Sigma Investments's 13F filing for Q1 2015, filed 15 May 2015.